North Star Asset Management Inc Crispr Therapeutics Ag Transaction History
North Star Asset Management Inc
- $2.26 Billion
- Q2 2025
A detailed history of North Star Asset Management Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, North Star Asset Management Inc holds 4,505 shares of CRSP stock, worth $308,277. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,505Holding current value
$308,277% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
539Shares Held
68.7MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$697 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$383 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$252 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$224 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$195 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.34B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....